Literature DB >> 10369797

Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy.

J P Greeves1, N T Cable, T Reilly, C Kingsland.   

Abstract

The effects of hormone deficiency at the menopause on muscle strength was examined in 10 healthy middle-aged women (1-3 years post-menopause) in a longitudinal trial over 39 weeks. Performance was compared with that of age-matched females (n=11) taking a course of hormone replacement therapy (HRT). Muscle strength of the quadriceps was measured isometrically at 90 degrees of knee flexion and at angular velocities of 1.05, 2.09 and 3.13 rad/s using an isokinetic dynamometer. Hand grip strength was assessed by means of a portable dynamometer. Measurements were taken every 13 weeks for 39 weeks. Significant decreases in isometric strength (-10%) and dynamic leg strength at 1.05 rad/s (-9%) were found in the post-menopausal women over 39 weeks. There was no change in strength in the HRT group. There were also no changes in leg strength at higher angular velocities or in grip strength for either the post-menopausal group or those taking HRT. While HRT preserved muscle strength, there was no evidence of a strengthening effect on skeletal muscle within this short period of treatment. A rapid loss of leg strength occurs post-menopausally in hormone-depleted women. HRT may offer protection against muscle weakness, although the hormone responsible for regulating strength is not evident using this model.

Entities:  

Mesh:

Year:  1999        PMID: 10369797

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  27 in total

Review 1.  Body composition and muscle performance during menopause and hormone replacement therapy.

Authors:  S Sipilä
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  Does oral contraceptive use affect maximum force production in women?

Authors:  K J Elliott; N T Cable; T Reilly
Journal:  Br J Sports Med       Date:  2005-01       Impact factor: 13.800

3.  Power output, isometric strength and steadiness in the leg muscles of pre- and postmenopausal women; the effects of hormone replacement therapy.

Authors:  Serena F Carville; Olga M Rutherford; Di J Newham
Journal:  Eur J Appl Physiol       Date:  2005-11-10       Impact factor: 3.078

4.  A rehabilitation exercise program to remediate skeletal muscle atrophy in an estrogen-deficient organism may be ineffective.

Authors:  Marybeth Brown; J Andries Ferreira; Andrea M Foley; Kaitlyn M Hemmann
Journal:  Eur J Appl Physiol       Date:  2011-04-17       Impact factor: 3.078

Review 5.  Physical Activity and Physical Function: Moving and Aging.

Authors:  Sheila A Dugan; Kelley Pettee Gabriel; Brittney S Lange-Maia; Carrie Karvonen-Gutierrez
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

Review 6.  Hormone therapy and skeletal muscle strength: a meta-analysis.

Authors:  Sarah M Greising; Kristen A Baltgalvis; Dawn A Lowe; Gordon L Warren
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-26       Impact factor: 6.053

7.  Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low-magnitude mechanical signals.

Authors:  Danielle M Frechette; Divya Krishnamoorthy; Benjamin J Adler; M Ete Chan; Clinton T Rubin
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

8.  Preventive effects of raloxifene treatment on agerelated weight loss in postmenopausal women.

Authors:  Tomohiko Urano; Masataka Shiraki; Tatsuhiko Kuroda; Shiro Tanaka; Kazuhiro Uenishi; Satoshi Inoue
Journal:  J Bone Miner Metab       Date:  2016-01-11       Impact factor: 2.626

9.  Does hormone replacement therapy prevent lateral rotatory spondylolisthesis in postmenopausal women?

Authors:  Catherine Marty-Poumarat; Agnès Ostertag; Claude Baudoin; Michèle Marpeau; Marie-Christine de Vernejoul; Martine Cohen-Solal
Journal:  Eur Spine J       Date:  2011-10-28       Impact factor: 3.134

Review 10.  Optimal management of sarcopenia.

Authors:  Louise A Burton; Deepa Sumukadas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.